[1] 王征,赵锋,霍勇,等. 高危队列人群血浆氨基末端脑钠肽前体 浓度与左室舒张功能相关性的探讨[J]. 临床心血管病杂志, 2010, 25(5):364-368.
[2] 韦丙奇,张健,杨跃进,等. N 末端B 型利钠肽原在陈旧性心肌 梗死患者中诊断心力衰竭的价值[J]. 中华心血管病杂志, 2012,4 0(1):34-38.
[3] Dyer AK,Barnes AP,Fixler DE,et al. Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients[J]. Am Heart J,2012, 163(4):595-600.
[4] Lindahl B,Lindck J,Jernberg T,et al. Serial analyses of Nterminal pro-B-type natriuretic peptide in patients with non-STsegment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC) -Ⅱ substudy[J]. J Am Coll Cardiol,2005,45 (4 ):533-541.
[5] Jarai R, Iordanova N, Jarai R, et al. Prediction of clinical outcome in patients with non-ST-elevation acute coronary syndrome(NSTEACS) using the TIMI risk score extended by N-terminal pro-brain natriuretic peptide levels[J]. Wien Klin Wochenschr,2007,119 (21 /22):626-632.
[6] Kim MK,Chung WY,Cho YS, et al. Serum N-terminal pro-B-type natriuretic peptide levels at the time of hospital admission predict of microvascular obstructions after primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction [J]. J Interv Cardiol,2011, 24(1):34-41.